Health Technology Assessment Consumer Consultative Committee March 2019 meeting communiqué

20 May 2019 - A communiqué from the March 2019 meeting of the HTA Consumer Consultative Committee has been published. ...

Read more →

Two additional countries to benefit from EU-US mutual recognition agreement for inspections

30 April 2019 - In April 2019, the US FDA confirmed the capability of two additional European Union Member States ...

Read more →

Health Canada approves new drug to treat metastatic breast cancer through international and domestic joint reviews

9 April 2019 - Canadians want improved access to the most recent and innovative treatment options for themselves and their ...

Read more →

International work-sharing initiative - abemaciclib (Verzenio)

9 April 2019 - Abemaciclib (Verzenio) is the second medicine to be registered on the Australian Register of Therapeutic Goods ...

Read more →

An EU wide approach to HTA: an irrelevant development or an opportunity not to be missed?

14 March 2019 - An EU-wide cooperation on HTA has been proposed recently by the European Commission, focusing on relative effectiveness ...

Read more →

NICE collaborates with the Canadian Agency for Drugs and Technology in Health to offer parallel scientific advice

6 February 2019 - NICE and the Canadian Agency for Drugs and Technology in Health have launched a new collaboration to ...

Read more →

New opportunity: parallel scientific advice from CADTH and NICE

6 February 2019 - CADTH is pleased to announce a new collaboration with England’s NICE (National Institute for Health and ...

Read more →

ICER launches international collaborative to develop new methods to guide value-based pricing of potential cures

23 January 2019 - NICE in the UK and CADTH in Canada among international agencies participating; public input on key methodological ...

Read more →

Our door is open: FDA puts patients first

18 December 2018 - We believe patients are experts when it comes to their health conditions.  ...

Read more →

FDA announces pilot program with WHO to expedite review of HIV drug applications

30 November 2018 - The U.S. FDA today announced a plan to work with the WHO to pilot a process to ...

Read more →

Comparable overseas reports pathway - first registration decision

2 November 2018 - Cabozantinib (Cabometyx) is the first medicine to be registered on the Australian Register of Therapeutic Goods ...

Read more →

Update on the Australia-Canada Mutual Recognition Agreement

1 November 2018 - Common Statement regarding inclusion of Active Pharmaceutical Ingredient in Australia-Canada Mutual Recognition Agreement (as of November 1, ...

Read more →

FDA and DHS increase coordination of responses to medical device cybersecurity threats under new partnership; a part of the two agencies’ broader effort to protect patient safety

16 October 2018 - As part of the Administration’s ongoing efforts to strengthen cybersecurity in health care, the U.S. FDA ...

Read more →

Early dialogue in Europe: perspectives on value, challenges, and continuing evolution

24 September 2018 - This study aims to assess participants’ views on previous experiences, the current situation and future perspectives for ...

Read more →

Portugal to also benefit from EU-US mutual recognition agreement for inspections

20 September 2018 - Agreement now operational between 15 EU Member States and FDA. ...

Read more →